USA

Through the HELM Cluster, the emirate has brought together research institutions, advanced healthcare infrastructure, genomics programs, manufacturing capabilities, and distribution networks within a single ecosystem.

The announcement follows growing calls from public health advocates and humanitarian organizations urging the US government to share available supplies of MBP134 to support outbreak control efforts in Central Africa.

The acquisition is expected to strengthen Merck’s position in the rapidly growing life sciences sector, particularly in areas such as cell and gene therapy, precision diagnostics, multi-omics research, and biopharmaceutical manufacturing.

Evaluators examined how the hospital manages patient care across multiple departments, including safety protocols, infection control, medication handling, and continuous quality improvement processes.

The acquisition ranks among AbbVie’s largest transactions in recent years and reflects the company’s strategy to expand its next-generation immunology medicines as competition intensifies across the sector.

Under the agreement, Biogen will integrate RayThera’s portfolio of anti-inflammatory and immune-modulating candidates into its broader research and development engine.

Researchers will assess the drug’s efficacy and safety in patients with acute coronary syndrome (ACS), recent myocardial infarction, ischemic stroke, and peripheral arterial disease.

The Commission argued that without the divestitures, the merged company could gain the ability to exert unilateral control over pricing in these markets.

More than 3 million cases of complicated UTIs are recorded annually in the United States, and treatment failure affects up to one-third of patients.

The agreement brings together Protillion’s computational biology platform with Merck’s established drug development expertise to support the discovery of next-generation therapies.